Mesenchymal fibroblasts may release TGF-β and stromal cell-derived factor-1 (SDF1), which function in concert through distinct signaling pathways to sustain mesenchymal fibroblast differentiation into myofibroblasts during cancer development. Here, CXCL12 is linked to cancer.